Group 1 - Honghe Technology plans to increase capital by 300 million yuan to its wholly-owned subsidiary Huangshi Honghe through debt-to-equity conversion, raising its registered capital from 700 million yuan to 1 billion yuan [1] - Huaxia Happiness has completed debt restructuring amounting to approximately 192.67 billion yuan, with a total of 24 billion yuan in overdue debts as of August 31 [1] - Chengyi Pharmaceutical's controlling shareholder plans to reduce its stake by up to 1.18%, amounting to 387,560 shares [1][2] Group 2 - Yuanwang Valley received a warning letter from the Shenzhen Securities Regulatory Bureau for failing to halt trading when its controlling shareholder's stake changed to a multiple of 5% [2] - Gongjin Co. received government subsidies of 8.9 million yuan, accounting for 11.13% of its latest audited net profit [3] - Maiwei Biotech's application for the listing of 9MW0813 injection has been accepted by the National Medical Products Administration [4] Group 3 - Jianfeng Group plans to repurchase shares worth between 20 million and 40 million yuan at a maximum price of 12.42 yuan per share [6] - Ankai Micro plans to invest 20 million yuan to acquire a 4% stake in Shiqi Future [7] - Pinming Technology's stock will continue to be suspended as it is actively pursuing a significant matter that may lead to a change in control [8] Group 4 - China Communications has signed new contracts worth 256.34 billion yuan from January to August, with domestic contracts totaling 206.05 billion yuan [18] - Round Express reported a revenue of 5.39 billion yuan in August, a year-on-year increase of 9.82% [38] - China Pacific Insurance's original insurance premium income reached 217.05 billion yuan from January to August, up 13.2% year-on-year [39] Group 5 - *ST Chuangxing's chairman is under investigation, and the general manager will act as the chairman during this period [40] - Fengshan Group signed a technical development contract with Tsinghua University for a project related to sodium-ion battery electrolytes [40] - Yongxin Optical stated that its optical components related to lithography machines account for less than 1% of its revenue [41] Group 6 - Tianyuan Dike's subsidiary received a government subsidy of 3.77 million yuan, representing 16.27% of its latest audited net profit [42] - Huaxiang Co. plans to issue convertible bonds to raise no more than 1.308 billion yuan for various projects [43] - Wolong Electric Drive reported that its robot-related products accounted for only 2.71% of total revenue in the first half of the year [44]

Group 1 - The core point of the article is that Qingxin Environment (002573) plans to purchase liability insurance for the company and its directors, supervisors, and senior management to enhance risk management and protect the rights of the company and its investors [1] - As of September 19, 2025, Qingxin Environment's stock closed at 3.92 yuan, down 1.51% from the previous trading day, with a total market value of 5.548 billion yuan [1] - The company reported a trading volume of 61.568 million yuan and a turnover rate of 1.11% on the same day [1] Group 2 - The liability insurance will have a compensation limit of no more than 50 million yuan per year, with a total premium not exceeding 150,000 yuan per year, and the insurance period is set for 12 months [1] - The board of directors will abstain from voting on this proposal due to their status as insured parties, and the proposal will be submitted for approval at the company's second extraordinary general meeting of shareholders in 2025 [1] - The board of directors has requested authorization from the shareholders' meeting to allow management to handle matters related to the purchase of liability insurance, including determining the insurance company, insurance amount, insurance terms, signing documents, and managing renewal or reinsurance matters [1]

Group 1 - Yipinhong's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical, received approval from the National Medical Products Administration for a supplemental application for Oseltamivir Phosphate Capsules, allowing the addition of a 45mg specification and changes to the excipient quantities in the formulation, as well as modifications to packaging materials and containers [1] - Guanghetong's issuance of up to 155 million overseas listed foreign shares (H shares) has been filed with the China Securities Regulatory Commission [1] - Zhenghai Magnetic Materials' "Zhenghai Convertible Bonds" will stop conversion after the trading session on September 19, with unconverted bonds being forcibly redeemed at a price of 100.5 yuan per bond, potentially leading to investment losses for investors [1] Group 2 - Qingxin Environment plans to purchase liability insurance for the company and its directors and supervisors, with a total premium not exceeding 150,000 yuan per year and a coverage period of 12 months [1]

Group 1 - Yipinhong's subsidiary Guangzhou Yipinhong Pharmaceutical received approval from the National Medical Products Administration for a supplemental application for Oseltamivir Phosphate Capsules, allowing the addition of a 45mg specification and changes to excipient quantities and packaging materials [1] - The drug is indicated for the treatment of influenza A and B in adults and children aged 1 year and older, and for the prevention of influenza A and B in adults and adolescents aged 13 years and older [1] Group 2 - Guanghe Tong has received approval from the China Securities Regulatory Commission for the issuance of no more than 155 million overseas listed foreign shares (H shares) [2] - Zhenghai Magnetic Materials' "Zhenghai Convertible Bonds" will stop conversion after the trading session on September 19, with remaining convertible bonds being forcibly redeemed at a price of 100.5 yuan per bond [2] - Investors may face potential losses if the bonds are forcibly redeemed [2] Group 3 - Qingxin Environment plans to purchase liability insurance for the company and its directors and senior management, with a total premium not exceeding 150,000 yuan per year for a duration of 12 months [3]

Group 1 - The company plans to purchase liability insurance for itself and all directors, supervisors, and senior management, with a compensation limit not exceeding 50 million yuan per year [1] - The total premium for the insurance will not exceed 150,000 yuan per year [1] - The proposal has been approved by the company's 6th Board of Directors at its 21st meeting and the 6th Supervisory Board at its 14th meeting, and it will be submitted to the shareholders' meeting for authorization [1]

证券代码：002573 证券简称：清新环境 公告编号：2025-058 公司于 2025 年 8 月 5 日召开的第六届董事会第二十一次会议、第六届监事会第十 四次会议审议了《关于购买公司及董监高人员责任保险的议案》。由于公司董事作为责 任险的被保险对象，属于利益相关方，董事会全体成员回避表决，该议案直接提交公司 2025 年第二次临时股东大会审议。现将有关事项公告如下： 一、董监高责任险具体方案 1.投保人：北京清新环境技术股份有限公司 2.被保险对象：北京清新环境技术股份有限公司以及公司董事、监事及高级管理人 员等 北京清新环境技术股份有限公司 关于拟购买公司及董监高人员责任保险的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 为进一步完善北京清新环境技术股份有限公司（以下简称"公司"）风险管理体系， 降低运营风险，促进公司董事、监事、高级管理人员等在各自职责范围内更充分地行使 权利、履行职责，保障公司和投资者的权益，根据《上市公司治理准则》及相关法律法 规的规定，公司拟为公司和全体董事、监事、高级管理人员等购买责任保险（以下简称 "董监高责任险"） ...

Core Viewpoint - Beijing Qingxin Environment Technology Co., Ltd. is convening its second extraordinary general meeting of shareholders in 2025 on September 29, 2025, to discuss a proposal for providing guarantees for its controlling subsidiary [1][2]. Group 1: Meeting Details - The extraordinary general meeting is scheduled for September 29, 2025, at 15:00 [4]. - The meeting will be conducted in a hybrid format, combining on-site voting and online voting [5]. - The record date for shareholders to attend the meeting is September 23, 2025 [6]. Group 2: Proposal and Voting - A proposal to provide guarantees for a controlling subsidiary has been submitted for consideration at the meeting [2]. - The controlling shareholder, Sichuan Ecological Environmental Protection Industry Group, holds 596,118,979 shares, representing 42.12% of the total share capital, qualifying them to propose this agenda item [2]. - The meeting will include separate voting for minority shareholders on matters affecting their interests [7]. Group 3: Registration and Participation - Shareholders must register to attend the meeting, with specific requirements for natural and legal persons [8]. - Registration will take place on September 24, 2025, from 9:30 to 11:30 and 13:30 to 15:30 [8]. - Contact information for inquiries regarding the meeting is provided, including a phone number and email address [10].

证券代码：002573 证券简称：清新环境 公告编号：2025-057 北京清新环境技术股份有限公司 经核查，截至本公告披露日，四川省生态环保集团直接持有公司 596,118,979 股股 份，占公司总股本 42.12%，四川省生态环保集团具备提出临时提案的资格，上述临时提 案在股东大会召开 10 日前提出并书面提交本次股东大会召集人，且其提出的临时提案 的内容属于股东大会职权范围，有明确的议题和具体决议事项，符合《中华人民共和国 公司法》和《公司章程》等有关规定。作为本次股东大会的召集人，公司董事会同意将 上述临时提案提交 2025 年第二次临时股东大会审议。除增加上述临时提案外，本次股 东大会的召开方式、时间、地点、股权登记日和其他会议事项均不变，现将 2025 年第 二次临时股东大会具体事项补充通知如下： 一、召开会议的基本情况 1.股东大会届次：2025 年第二次临时股东大会 2.股东大会的召集人：本次股东大会由公司董事会召集。 3.会议召开的合法、合规性：本次股东大会的召开符合法律法规、深圳证券交易所 业务规则和《公司章程》的规定。 关于2025年第二次临时股东大会增加临时提案暨补充通知的公告 本公 ...

一、董事会会议召开情况 北京清新环境技术股份有限公司（以下简称"公司"）第六届董事会第二十三次会议通知于2025年9月9日 以通讯方式向全体董事发出。本次董事会于2025年9月12日采用通讯表决方式召开。本次会议应出席董 事8人，实际出席会议董事8人，本次会议由公司董事长陈竹先生主持。本次董事会会议的召开符合《中 华人民共和国公司法》和《公司章程》的有关规定。 二、董事会会议审议情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002573 证券简称：清新环境 公告编号：2025-054 北京清新环境技术股份有限公司 第六届董事会第二十三次会议 决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 （一）以8票同意、0票反对、0票弃权审议通过了《关于变更2025年度审计机构的议案》 董事会认为致同会计师事务所（特殊普通合伙）具有从事证券、期货相关业务执业资格，具备从事上市 公司审计业务的工作经验，能够满足公司审计工作的要求。董事会同意聘任致同会计师事务所（特殊普 通合伙）为公司2025年度财务报告及内部控制审计机构。 本议案尚需提交股东大会 ...

Group 1 - On September 12, Qingxin Environment executed a block trade of 2 million shares, with a transaction amount of 7.84 million yuan, accounting for 12.93% of the total transaction volume for that day [1][2] - The transaction price was 3.92 yuan, which represents a discount of 3.69% compared to the market closing price of 4.07 yuan [1][2]